390 related articles for article (PubMed ID: 34455688)
1. Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis.
Chow JH; Yin Y; Yamane DP; Davison D; Keneally RJ; Hawkins K; Parr KG; Al-Mashat M; Berger JS; Bushardt RL; Mazzeffi MA; Nelson SJ
J Thromb Haemost; 2021 Nov; 19(11):2814-2824. PubMed ID: 34455688
[TBL] [Abstract][Full Text] [Related]
2. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.
Meizlish ML; Goshua G; Liu Y; Fine R; Amin K; Chang E; DeFilippo N; Keating C; Liu Y; Mankbadi M; McManus D; Wang SY; Price C; Bona RD; Ochoa Chaar CI; Chun HJ; Pine AB; Rinder HM; Siner JM; Neuberg DS; Owusu KA; Lee AI
Am J Hematol; 2021 Apr; 96(4):471-479. PubMed ID: 33476420
[TBL] [Abstract][Full Text] [Related]
3. Dual antiplatelet therapy reduces stroke but increases bleeding at the time of carotid endarterectomy.
Jones DW; Goodney PP; Conrad MF; Nolan BW; Rzucidlo EM; Powell RJ; Cronenwett JL; Stone DH
J Vasc Surg; 2016 May; 63(5):1262-1270.e3. PubMed ID: 26947237
[TBL] [Abstract][Full Text] [Related]
4. One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.
Danchin N; Puymirat E; Cayla G; Cottin Y; Coste P; Gilard M; Goldstein P; Braun F; Belle L; Montalescot G; Ferrières J; Schiele F; Simon T;
Circ Cardiovasc Interv; 2018 Sep; 11(9):e007241. PubMed ID: 30354592
[TBL] [Abstract][Full Text] [Related]
5. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018
[TBL] [Abstract][Full Text] [Related]
6. Mortality in primary angioplasty patients starting antiplatelet therapy with prehospital prasugrel or clopidogrel: a 1-year follow-up from the European MULTIPRAC Registry.
Goldstein P; Grieco N; Ince H; Danchin N; Ramos Y; Goedicke J; Clemmensen P
Vasc Health Risk Manag; 2016; 12():143-51. PubMed ID: 27143908
[TBL] [Abstract][Full Text] [Related]
7. Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.
Haji Aghajani M; Moradi O; Amini H; Azhdari Tehrani H; Pourheidar E; Rabiei MM; Sistanizad M
J Med Virol; 2021 Sep; 93(9):5390-5395. PubMed ID: 33913549
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome.
Spoendlin J; Gagne JJ; Lewey JJ; Patorno E; Schneeweiss S; Desai RJ
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1361-1370. PubMed ID: 30379372
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study.
Sokolski M; Reszka K; Adamik B; Kilis-Pstrusinska K; Lis W; Pomorski M; Sokolowski J; Doroszko A; Madziarska K; Jankowska EA; Protasiewicz M
Sci Rep; 2024 Feb; 14(1):4832. PubMed ID: 38413716
[TBL] [Abstract][Full Text] [Related]
10. Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19.
Chow JH; Rahnavard A; Gomberg-Maitland M; Chatterjee R; Patodi P; Yamane DP; Levine AR; Davison D; Hawkins K; Jackson AM; Quintana MT; Lankford AS; Keneally RJ; Al-Mashat M; Fisher D; Williams J; Berger JS; Mazzeffi MA; Crandall KA;
JAMA Netw Open; 2022 Mar; 5(3):e223890. PubMed ID: 35323950
[TBL] [Abstract][Full Text] [Related]
11. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
Viecca M; Radovanovic D; Forleo GB; Santus P
Pharmacol Res; 2020 Aug; 158():104950. PubMed ID: 32450344
[TBL] [Abstract][Full Text] [Related]
12. "Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States.
Larmore C; Effron MB; Molife C; DeKoven M; Zhu Y; Lu J; Karkare S; Lieu HD; Lee WC; Vetrovec GW
Catheter Cardiovasc Interv; 2016 Oct; 88(4):535-544. PubMed ID: 26577386
[TBL] [Abstract][Full Text] [Related]
13. Indication Bias Explains Some of the Observed Increased Mortality Associated With Use of Prehospital Intravenous Fluids in a Pediatric Trauma Population.
Garwe T; Johnson JJ; Letton RW
Acad Emerg Med; 2016 Jan; 23(1):83-92. PubMed ID: 26719966
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry.
Santoro F; Núñez-Gil IJ; Vitale E; Viana-Llamas MC; Romero R; Maroun Eid C; Feltes Guzman G; Becerra-Muñoz VM; Fernández Rozas I; Uribarri A; Alfonso-Rodriguez E; García Aguado M; Huang J; Castro Mejía AF; Garcia Prieto JF; Elola J; Ugo F; Cerrato E; Signes-Costa J; Raposeiras Roubin S; Jativa Mendez JL; Espejo Paeres C; López Masjuan A; Marin F; Guerra F; El-Battrawy I; Cortese B; Ramakrishna H; Perez-Villacastín J; Fernandez-Ortiz A; Brunetti ND
J Am Heart Assoc; 2022 Jul; 11(13):e024530. PubMed ID: 35730631
[TBL] [Abstract][Full Text] [Related]
15. [The effect of antiplatelet therapy on the course of COVID-19].
Edilgireeva LA; Sadulaeva TA; Zakharov VV; Vakhnina NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):16-21. PubMed ID: 35394714
[TBL] [Abstract][Full Text] [Related]
16. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K
J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493
[TBL] [Abstract][Full Text] [Related]
18. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis.
Meizlish ML; Goshua G; Liu Y; Fine R; Amin K; Chang E; DeFilippo N; Keating C; Liu Y; Mankbadi M; McManus D; Wang S; Price C; Bona RD; Chaar CIO; Chun HJ; Pine AB; Rinder HM; Siner J; Neuberg DS; Owusu KA; Lee AI
medRxiv; 2021 Jan; ():. PubMed ID: 33469595
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
[TBL] [Abstract][Full Text] [Related]
20. Utility of GRACE and ACUITY-HORIZONS risk scores to guide dual antiplatelet therapy in Korean patients with acute myocardial infarction undergoing drug-eluting stenting.
Sim DS; Jeong MH; Kim HS; Gwon HC; Seung KB; Rha SW; Chae SC; Kim CJ; Cha KS; Park JS; Yoon JH; Chae JK; Joo SJ; Choi DJ; Hur SH; Seong IW; Cho MC; Kim DI; Oh SK; Ahn TH; Hwang JY;
J Cardiol; 2018 Nov; 72(5):411-419. PubMed ID: 29764713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
